This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr. Hien Zhao, PhD
Vice President, Neuroscience Research at Ionis Pharmaceuticals
Speaker

Profile

Hien T. Zhao, PhD, is Vice President of Neuroscience Research at Ionis Pharmaceuticals, where she leads antisense oligonucleotide-based therapeutic discovery for neurodegenerative and neurological disorders. Her work spans applications of antisense oligonucleotides in preclinical models of Parkinson’s disease, prion disease, peripheral neuropathies, and related conditions. She is an inventor on multiple patents for RNA-lowering therapeutics targeting disease-relevant genes. Dr. Zhao’s research has contributed to validating RNA-targeted approaches as promising strategies for treating CNS diseases.

Agenda Sessions

  • Leveraging IGF1R Receptor for Antisense Delivery

    9:30am